Douglas F Nixon Selected Research

Douglas F Nixon Research Topics

Disease

47	Infections 12/2021 - 01/2002
10	HIV Infections (HIV Infection) 10/2022 - 03/2006
10	Neoplasms (Cancer) 01/2022 - 03/2003
9	COVID-19 10/2022 - 01/2020
9	Viremia 12/2020 - 01/2002
8	Disease Progression 12/2014 - 01/2007
6	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2017 - 02/2012
3	Virus Diseases (Viral Diseases) 01/2021 - 03/2004
3	Sexually Transmitted Diseases (Sexually Transmitted Disease) 07/2004 - 11/2002
2	Malaria 01/2022 - 01/2012
2	Zika Virus Infection 01/2019 - 01/2017
1	Coronavirus Infections 10/2022
1	Poliomyelitis (Polio) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Uveal melanoma 01/2022
1	Bipolar Disorder (Manic Depressive Psychosis) 10/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Genetic Risk Score 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Carcinogenesis 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020
1	Inflammation (Inflammations) 01/2018
1	Shock 01/2018
1	Hyperalgesia 01/2018
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Persistent Infection 01/2018
1	Pain (Aches) 01/2018
1	Microcephaly 01/2017
1	Common Variable Immunodeficiency 07/2016
1	Weight Loss (Weight Reduction) 04/2016

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 12/2021 - 04/2004
9	RNA (Ribonucleic Acid)IBA 12/2021 - 12/2003
9	CytokinesIBA 01/2021 - 02/2002
8	VaccinesIBA 01/2022 - 04/2004
6	AntigensIBA 01/2020 - 06/2004
5	Interferon-gamma (Interferon, gamma)IBA 01/2021 - 01/2006
5	Messenger RNA (mRNA)IBA 01/2020 - 01/2014
5	Peptides (Polypeptides)IBA 08/2017 - 01/2006
4	Antiviral Agents (Antivirals)IBA 12/2021 - 03/2004
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2012
4	AntibodiesIBA 08/2017 - 01/2012
3	Pharmaceutical PreparationsIBA 10/2022 - 11/2002
3	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022 - 01/2008
3	DNA Transposable Elements (Element, IS)IBA 12/2021 - 08/2012
3	InterferonsIBA 11/2015 - 01/2008
2	Transcription Factors (Transcription Factor)IBA 12/2021 - 06/2018
2	HLA-DR Antigens (HLA-DR)IBA 01/2018 - 01/2018
2	InterleukinsIBA 01/2017 - 01/2008
2	Immunoglobulin G (IgG)IBA 07/2016 - 01/2012
2	EnzymesIBA 01/2016 - 07/2011
2	ElementsIBA 01/2014 - 08/2012
2	EpitopesIBA 03/2013 - 01/2010
2	AutoantigensIBA 08/2012 - 07/2009
2	LigandsIBA 02/2012 - 01/2007
2	HLA-B Antigens (HLA-B)IBA 02/2012 - 01/2010
2	KIR ReceptorsIBA 02/2010 - 01/2007
2	Interleukin-2 (IL2)IBA 01/2008 - 04/2006
2	Granzymes (Granzyme)IBA 03/2006 - 07/2004
2	PerforinIBA 03/2006 - 07/2004
1	lopinavir-ritonavir drug combination (Kaletra)FDA Link 10/2022
1	TESIBA 12/2021
1	Heme Oxygenase-1IBA 12/2021
1	Excipients (Suspending Agents)IBA 10/2021
1	LithiumIBA 10/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	BCG Vaccine FDA Link 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Vascular Endothelial Growth Factor DIBA 01/2021
1	Atorvastatin (Lipitor)FDA Link 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2020
1	ParaffinIBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	nef Gene Products (nef Gene Product)IBA 08/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2018
1	Macrophage Colony-Stimulating FactorIBA 11/2018
1	CD4 Antigens (CD4 Antigen)IBA 11/2018
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2018
1	allatostatinIBA 01/2018
1	HLA-C Antigens (HLA-C)IBA 01/2018
1	Biological ProductsIBA 01/2018
1	Ligand-Gated Ion ChannelsIBA 01/2018
1	Viral ProteinsIBA 08/2017
1	Protease Inhibitors (Protease Inhibitor)IBA 02/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	Immunoglobulin A (IgA)IBA 07/2016
1	Glucose (Dextrose)FDA LinkGeneric 04/2016
1	HDL-triglycerideIBA 04/2016

Therapy/Procedure

10	Therapeutics 01/2020 - 01/2002
6	Art Therapy 12/2020 - 03/2006
6	Highly Active Antiretroviral Therapy (HAART) 12/2014 - 01/2002
3	Immunotherapy 01/2022 - 01/2020
2	Telescopes 12/2021 - 01/2020
2	Chemoprevention 06/2016 - 02/2016
1	Mass Drug Administration 01/2022